On February 2, 2023, the company announced an increase in its equity buyback plan by $1,000 million, thereby increasing the total authorization to $9,500 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,734 GBX | +0.29% | +4.87% | +19.54% |
05-03 | GSK : DZ Bank remains Neutral | ZD |
05-03 | GSK plc : Back on track |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
1,734 GBX | +0.29% | +4.87% | 88.72B | ||
137.4 USD | +0.81% | +2.38% | 15.26B | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.54% | 88.72B | |
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
-3.40% | 157B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- Quest Diagnostics Incorporated announces an Increase in Equity Buyback